C1-esterase inhibitor
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for C1-esterase inhibitor, covering 2011-04-22 to 2022-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients [Phase 3]